Prometheus Biosciences

-$0.01 (-0.04%) As of 2:02 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell RXDX and other ETFs, options, and stocks.

About RXDX

Prometheus Biosciences, Inc. engages in operation of a biopharmaceutical company. It focuses on the discovery, development, and commercialization of novel precision therapeutics and companion diagnostics for patients living with unmet needs in gastroenterology and autoimmune diseases.

CEO
Mark C. Mckenna
Employees
33
Headquarters
San Diego, California
Founded
2016

RXDX Key Statistics

Market Cap
933.95M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
72.87K
High Today
$24.76
Low Today
$24.03
Open Price
$24.66
Volume
6.24K
52 Week High
$30.64
52 Week Low
$16.11

RXDX Earnings

-$1.67
-$1.11
-$0.56
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 10, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure